Clinical Trial

Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin

Name: Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin — clinical trial record (NCT07699276)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting

Trial Details

NCT Number	NCT07699276
Lead Sponsor	Mahidol University
Conditions	Cancer (Solid Tumors), Vomiting, Cisplatin, Olanzapine
Enrollment	95 participants
Start Date	2026-02-10
Primary Completion	2027-10-01 (estimated)
Study Completion	2027-11-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-13